tirzepatide φαρμακο Compounded (GLP-1/GIP) Tirzepatide | DirectMeds

Read about the scientists research journey: | 30 comments on LinkedIn

Drug repurposing was common (22.2%), notably involving semaglutide and liraglutide, originally approved for type 2 diabetes

Semaglutide is a GLP-1 analogue with 94% sequence homology to human GLP-1. Semaglutide acts as a GLP-1 receptor agonist that selectively binds to and activates the GLP-1 receptor, the target for native GLP-1. GLP-1 is a physiological hormone that has multiple actions on glucose, mediated by the GLP-1 receptors. The principal mechanism of protraction resulting in the long half-life of semaglutide is albumin binding, which results in decreased renal clearance and protection from metabolic degradation. Furthermore, semaglutide is stabilized against degradation by the DPP-4 enzyme. Semaglutide reduces blood glucose through a mechanism where it stimulates insulin secretion and lowers glucagon secretion, both in a glucose-dependent manner. Thus, when blood glucose is high, insulin secretion is stimulated and glucagon secretion is inhibited. The mechanism of blood glucose lowering also involves a minor delay in gastric emptying in the early postprandial phase

It matters.

We focus on innovation and quality, aiming to provide high-quality slimming products and services for people who love life and focus on green slimming.

Weight Loss Treatment, Peptide Therapy, Anti-Aging Therapy, IV Drip Therapy, Sexual Health Treatment, Advanced Blood Testing, and General Wellness.